Welcome to our dedicated page for Aesthetic Medical International Holdings Group Ltd. American Depositary Shares SEC filings (Ticker: AIH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The SEC filings page for Aesthetic Medical International Holdings Group Limited (historically Nasdaq: AIH, now quoted on OTCQX as PAIYY) provides access to the company’s regulatory disclosures filed with the U.S. Securities and Exchange Commission. These documents include Form 6-K current reports and related exhibits in which AIH presents financial and operational information for its aesthetic medical services business in mainland China.
In its filings, AIH reports unaudited financial results for interim periods, detailing revenue by service category, gross profit and margin, selling, general and administrative expenses, EBITDA, adjusted EBITDA, and adjusted profit or loss. The company also discloses operational data such as total active customers, the number of treatment cases by type (energy-based treatments, minimally invasive aesthetic treatments, surgical treatments, and general healthcare and other aesthetic services), and average spending per customer.
AIH’s SEC reports explain how non-IFRS measures like EBITDA and adjusted EBITDA are calculated and provide reconciliations to the most directly comparable IFRS measures. Filings may also discuss cash and cash equivalents, net current asset or liability positions, borrowings, and liquidity and capital resources.
Beyond financial data, the filings describe corporate and capital structure developments, including share transfers, conversions of convertible notes into ordinary shares, issuances of warrants, and releases of share pledges. They also summarize changes in the board of directors and committee compositions, as well as changes in independent auditors. Certain filings reference interactions with stock exchanges, such as Nasdaq notifications, listing rule compliance matters, and subsequent trading of the company’s American Depositary Shares on over-the-counter markets.
On Stock Titan, AI-powered tools can help readers interpret these filings by highlighting key figures, summarizing management commentary, and organizing information on AIH’s aesthetic medical service categories, customer metrics, and capital structure.
Aesthetic Medical International reported operational shifts in the first half of 2025: total treatment cases fell by 2.3% year‑on‑year following reduced advertising spend, while the mix moved toward non‑surgical aesthetic procedures, which rose by 3.6 percentage points as a share of total treatments. Average spending per customer declined 1.2%, from RMB1,099 to RMB1,086, driven by increased promotional activity such as discounted live‑stream e‑commerce offers. The disclosure includes references to standard financial line items and balance sheet headings but lacks complete numeric tables or full financial results in the provided extract.